Showing results (21-30 of 510) with videos related to
Sort By:
Pageof 51
European Neurology|March 25, 2010
When do levodopa motor fluctuations first appear in Parkinson's disease?Fabrizio Stocchi, Peter Jenner, Jose A ObesoExpert Review of Neurotherapeutics|December 3, 2015
The efficacy of oral adenosine A(2A) antagonist istradefylline for the treatment of moderate to severe Parkinson's diseaseRuxandra Julia Vorovenci, Angelo AntoniniNeuro-Degenerative Diseases|July 10, 2010
Single-photon emission computed tomography in diagnosis and differential diagnosis of Parkinson's diseaseIoannis U Isaias, Angelo AntoniniFortschritte Der Neurologie-Psychiatrie|August 15, 2018
[Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease]Angelo Antonini, Wolfgang H JostExpert Review of Neurotherapeutics|December 18, 2008
Single photon-emission computed tomography imaging in early Parkinson's diseaseAngelo Antonini, Ioannis U IsaiasJournal of the Neurological Sciences|September 18, 2009
The pathophysiological basis of sensory disturbances in Parkinson's diseaseCarlos Juri, MariCruz Rodriguez-Oroz, Jose A ObesoMovement Disorders : Official Journal of the Movement Disorder Society|August 21, 2020
Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future OpportunitiesC Warren Olanow, Paolo Calabresi, Jose A ObesoThe Lancet. Neurology|July 22, 2006
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implicationsC Warren Olanow, Jose A Obeso, Fabrizio StocchiJournal of Parkinson'S Disease|August 29, 2016
Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging EvidenceHamad Alzahrani, Angelo Antonini, Annalena VenneriJournal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2010
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?Rüdiger Hilker, Angelo Antonini, Per OdinPageof 51